Transurethral Water Vapor Ablation: Potential for a Novel Prostate Cancer Management Strategy by Warlick CA, Spilseth BD, Dixon CM

“…At 6 months 4/15 subjects were identified for further management, two with residual GG2 cancer on the treated side, and two with newly identified GG2 cancer on the untreated contralateral side; one of two subjects with residual GG2 was ineligible for retreatment (unrelated myocardial infarction). …”
Get full text

The Sharp Upper Bounds of the Hankel Determinant on Logarithmic Coefficients for Certain Analytic Functions Connected with Eight-Shaped Domains by Pongsakorn Sunthrayuth, Naveed Iqbal, Muhammad Naeem, Yousef Jawarneh, Sallieu K. Samura

“…Furthermore, for the class BTsin, we look into the accurate bounds of the Zalcman inequality, Fekete-Szegö inequality along with D2,1Gg/2 and D2,2Gg/2. Importantly, all of these bounds are shown to be sharp.…”
Get full text

Focal therapy of prostate cancer: Use of artificial intelligence to define tumour volume and predict treatment outcomes by Wayne G. Brisbane, Alan M. Priester, Anissa V. Nguyen, Mark Topoozian, Sakina Mota, Merdie K. Delfin, Samantha Gonzalez, Kyla P. Grunden, Shannon Richardson, Shyam Natarajan, Leonard S. Marks

“…Utilising Unfold AI (FDA‐cleared 2022), which generates a 3D map of GG ≥ 2 PCa margins, we retrospectively estimated TV for each patient. …”
Get full text

Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1 by Ali H. Zahalka, Ethan Fram, Evan Garden, Lauren Howard, Emily Wiggins, Mustufa Babar, Jay Annam, Allison Reagan, Benjamin Eilender, Amanda deHoedt, Stephen J. Freedland, Ash Tewari, Kara L. Watts

“…Results A total of 467 men with initial GG ≤ 2 were included. Postdiagnosis atenolol use was associated with a decreased risk of pathologic upgrade to GG ≥ 3 on final repeat biopsy (HR 0.81, 95% CI 0.39–0.98). …”
Get full text